372 related items for PubMed ID: 7511017
1. Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma.
Haas R, Ehrhardt R, Witt B, Goldschmidt H, Hohaus S, Pförsich M, Ehrlich H, Färber L, Hunstein W.
Bone Marrow Transplant; 1993 Dec; 12(6):643-9. PubMed ID: 7511017
[Abstract] [Full Text] [Related]
2. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
Hohaus S, Goldschmidt H, Ehrhardt R, Haas R.
Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
[Abstract] [Full Text] [Related]
3. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Haas R, Moos M, Möhle R, Döhner H, Witt B, Goldschmidt H, Murea S, Flentje M, Wannenmacher M, Hunstein W.
Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159
[Abstract] [Full Text] [Related]
4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[Abstract] [Full Text] [Related]
5. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R.
Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
[Abstract] [Full Text] [Related]
6. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
Haas R, Murea S.
Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
[Abstract] [Full Text] [Related]
7. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Weisdorf D, Miller J, Verfaillie C, Burns L, Wagner J, Blazar B, Davies S, Miller W, Hannan P, Steinbuch M, Ramsay N, McGlave P.
Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
[Abstract] [Full Text] [Related]
8. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[Abstract] [Full Text] [Related]
9. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
Haematologica; 1997 Jun; 82(3):291-6. PubMed ID: 9234574
[Abstract] [Full Text] [Related]
10. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[Abstract] [Full Text] [Related]
11. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH, Schulman KA, Buckner CD.
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[Abstract] [Full Text] [Related]
12. Peripheral blood stem cells: in vivo biology and therapeutic potential.
Scheding S, Brugger W, Mertelsmann R, Kanz L.
Stem Cells; 1994 May; 12 Suppl 1():203-10; discussion 211. PubMed ID: 7535146
[Abstract] [Full Text] [Related]
13. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[Abstract] [Full Text] [Related]
14. Biological characterization of CD34+ cells mobilized into peripheral blood.
Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S.
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
[Abstract] [Full Text] [Related]
15. High-dose therapy with peripheral blood progenitor cell support in patients with non-Hodgkin's lymphoma.
Haas R, Murea S, Goldschmidt H, Döhner H, Moos M, Witt B, Eugenhart R, Wannenmacher M, Hunstein W.
Stem Cells; 1995 Dec; 13 Suppl 3():28-35. PubMed ID: 8747986
[Abstract] [Full Text] [Related]
16. Comparison of autografting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas.
Brice P, Divine M, Marolleau JP, Haioun C, Dalcortivo L, Sitthy X, Beaujean F, Norol F, Benbunan M, Reyes F.
Bone Marrow Transplant; 1994 Jul; 14(1):51-5. PubMed ID: 7524907
[Abstract] [Full Text] [Related]
17. Characterization of peripheral blood CD34+ progenitor cells mobilized with chemotherapy and granulocyte colony-stimulating factor.
Teofili L, Iovino MS, Sica S, Pierelli L, Menichella G, De Stefano V, Rumi C, Leone G.
Exp Hematol; 1994 Sep; 22(10):990-5. PubMed ID: 7522187
[Abstract] [Full Text] [Related]
18. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
Bolwell BJ, Fishleder A, Andresen SW, Lichtin AE, Koo A, Yanssens T, Burwell R, Baucco P, Green R.
Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
[Abstract] [Full Text] [Related]
19. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
Todisco E, Castagna L, Sarina B, Mazza R, Magagnoli M, Balzarotti M, Nozza A, Siracusano L, Timofeeva I, Anastasia A, Demarco M, Santoro A.
Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
[Abstract] [Full Text] [Related]
20.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
Page: [Next] [New Search]
